Reviewed by Professor Jørgen Bjerggaard Jensen (Aarhus University Hospital, Aarhus, Denmark) “A strategy alternating the urine marker Bladder EpiCheck® with cystoscopy in the surveillance of patients with low-grade intermediate-risk bladder cancer is cost-equivalent...
